Rwanda Military Hospital Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2016
NCT02964091
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Rwanda Military Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

ledipasvir (Harvoni) (1 trial)

sofosbuvir (sovaldi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2